Scarica l'app Stockscreener
0.134
80.66%
-0.559
Pre-mercato:
.11
-0.024
-17.91%
Affimed N V Borsa (AFMD) Ultime notizie
Affimed Faces Nasdaq Delisting Following Insolvency Filing - TipRanks
Affimed (AFMD) Faces Delisting from Nasdaq | AFMD Stock News - GuruFocus
Affimed Announces Receipt of Nasdaq Delisting Notice | AFMD Stoc - GuruFocus
Affimed shares to be delisted from Nasdaq after insolvency filing - Investing.com
HC Wainwright Downgrades Affimed N.V to Neutral From Buy - marketscreener.com
Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) - Seeking Alpha
Affimed (AFMD) Faces Downgrade Amid Insolvency Proceedings | AFM - GuruFocus
Affimed Stock to Be Delisted from Nasdaq, Trading Suspended May 20 Following Insolvency - Stock Titan
AFMD Stock Downgraded as Wells Fargo Slashes Price Target | AFMD - GuruFocus
Affimed (AFMD) Seeks Insolvency Proceedings Amid Financial Strug - GuruFocus
Health Care Stocks Face Broad Downturn As Sector Challenges Mount - Finimize
Wells Fargo Downgrades Affimed (AFMD) with New Price Target | AF - GuruFocus
Affimed downgraded to Equal Weight at Wells after insolvency filing - TipRanks
Leerink cuts Affimed stock target to $0.39, downgrades rating By Investing.com - Investing.com South Africa
Wells Fargo Downgrades Affimed to Equalweight From Overweight; Shares Plunge - marketscreener.com
Crude Oil Gains 3%; US Inflation Eases In April - Benzinga
Affimed (AFMD) Files for Insolvency Amid Financial Challenges - GuruFocus
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Affimed (AFMD) Resumes Trading, Offering Market Opportunities | - GuruFocus
Affimed shares crash after filing for the opening of insolvency proceedings - MSN
Affimed Announces Filing for the Opening of Insolvency Proceedin - GuruFocus
Affimed Shares Down, Halted in Premarket on Bankruptcy Application - MarketWatch
Affimed Files for Insolvency Amid Financial Challenges - TipRanks
This Caterpillar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Affimed Announces Filing for the Opening of Insolvency Proceedings - GlobeNewswire
This Rapid7 Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga
AFMD: Leerink Partners Downgrades Affimed with New Price Target - GuruFocus
Affimed (AFMD) Downgraded as Funding Prospects Dim | AFMD Stock News - GuruFocus
Leerink Downgrades Affimed to Market Perform From Outperform - marketscreener.com
Affimed (NASDAQ:AFMD) Now Covered by StockNews.com - Defense World
Affimed N.V.: Q2 Earnings Snapshot - Barchart.com
Affimed Delays Filing of 2024 Yearly Report - TipRanks
Affimed Shows Higher Exposure of AFM24 is Associated with Signif - GuruFocus
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting | AFMD Stock News - GuruFocus
Affimed Shows Higher Exposure of AFM24 is Associated with - GlobeNewswire
Affimed N.V. Reports Positive Findings on AFM24's Exposure-Outcome Analysis in Refractory Non-Small Cell Lung Cancer Patients - Nasdaq
Breakthrough: AFM24 Cancer Drug Achieves 33% Response Rate in Lung Cancer with New Dosing Strategy - Stock Titan
Affimed (NASDAQ:AFMD) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Affimed (NASDAQ:AFMD) Coverage Initiated at StockNews.com - Defense World
Affimed Announces Acceptance of Three Abstracts for Presentation - GuruFocus
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting | AFMD Stock News - GuruFocus
Affimed N.V. Announces Accepted Abstracts for Oral and Poster Presentations at ASCO 2025 Annual Meeting - Nasdaq
Affimed Announces Acceptance of Three Abstracts for - GlobeNewswire
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting - TradingView
Affimed Secures Coveted Oral Presentation Slot at ASCO 2025: Phase 2 Lymphoma and Lung Cancer Data - Stock Titan
Affimed faces Nasdaq delisting over share price rule By Investing.com - Investing.com Canada
Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode - NewsBreak: Local News & Alerts
Affimed Faces Nasdaq Delisting Risk Due to Share Price - TipRanks
Affimed faces Nasdaq delisting over share price rule - Investing.com Australia
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding - GuruFocus
Affimed (AFMD) Faces Nasdaq Delisting Risk Due to Low Share Price | AFMD Stock News - GuruFocus
Affimed (AFMD) Faces Nasdaq Delisting Risk Over Share Price - GuruFocus
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement | AFMD Stock News - GuruFocus
Affimed N.V. Receives Nasdaq Notification Regarding Minimum Bid Price Compliance - Nasdaq
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):